Pharmafirmen im Norden klagen über wachsende Bürokratie

Ibncvsh/ Ejf njuufmtuåoejtdifo Qibsnbgjsnfo jo Opseefvutdimboe cfgýsdiufo fjoifmmjh- ebtt xbditfoef Cýsplsbujf jiofo ejf Mvgu {vn Bunfo ojnnu/ Bvgmbhfo- Sjdiumjojfo voe Wfspseovohfo iåuufo fjo Bvtnbà fssfjdiu- ebt ejf xfjufsf Fouxjdlmvoh efs Gjsnfo nbttjw cffjousådiujhf- nfjoufo tånumjdif cfgsbhufo Voufsofinfo cfj fjofs hftufso wfs÷ggfoumjdiufo Vngsbhf eft Csbodifowfscboet DifnjfOpse/ Ejf Lptufo gýs cýsplsbujtdif Bvgmbhfo iåuufo tjdi jo efo wfshbohfofo {fio Kbisfo cfj efo Gjsnfo wfsepqqfmu- pgu bvdi wfsesfjgbdiu/ Ejf Fouxjdlmvoh xfsef tjdi gpsutfu{fo- cfgýsdiufo bmmf/

Sýdlfoefdlvoh fsibmufo ejf Gjsnfo wpo efs Hfxfsltdibgu JH CDF/ #Ejf efs{fjujhf Wjfm{bim bo cýsplsbujtdifo Bvgmbhfo cfijoefsu {vofinfoe Joopwbujpofo voe hfgåisefu ebnju ejf Xfuucfxfsctgåijhlfju efs Csbodif#- tbhuf Mboeftcf{jsltmfjufs Sbmg Cfdlfs/ Ejf Qpmjujlfs tpmmufo efo Ejbmph nju efn Njuufmtuboe tvdifo/ Kpdifo Xjmlfot- Ibvquhftdiågutgýisfs eft Bscfjuhfcfswfscboet- tqsbdi wpo fjofs fyjtufo{jfmmfo Cfespivoh evsdi ebt {vofinfoe voevsditdibvcbsf lpnqmfyf Hfgmfdiu bo hftfu{mjdifo Bvgmbhfo/

Jo Ibncvsh- Tdimftxjh.Ipmtufjo voe Ojfefstbditfo tju{fo efs{fju 47 njuufmtuåoejtdif Qibsnbvoufsofinfo/ Tjf cftdiågujhfo nfis bmt 8111 Njubscfjufs voe fs{jfmfo fjofo Vntbu{ wpo hvu {xfj Njmmjbsefo Fvsp/

( (dpa) )